| Product Unit Size | Cost | Quantity | Stock |
|---|
Ciprofloxacin is a second generation fluoroquinolone antibiotic that exhibits antibacterial activity against both gram negative and gram positive bacteria. Ciprofloxacin inhibits DNA gyrase and topoisomerase IV, preventing DNA replication.
| Cas No. | 85721-33-1 |
|---|---|
| Purity | ≥98% |
| Formula | C17H18FN3O3 |
| Formula Wt. | 331.34 |
| Chemical Name | 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1- piperazinyl)-3-quinolinecarboxylic acid |
| IUPAC Name | 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
| Synonym | Bay q 3939 |
| Melting Point | 255-257°C(dec.) |
| Solubility | Insoluble in water. Soluble in dilute hydrochloric acid. Soluble in hot DMSO or hot methanol. |
| Appearance | White Crystalline Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Rajendram M, Hurley KA, Foss MH, et al. Gyramides Prevent Bacterial Growth by Inhibiting DNA Gyrase and Altering Chromosome Topology. ACS Chem Biol. 2014 Apr 22. [Epub ahead of print]. PMID: 24712739.
Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician. 2002 Feb 1;65(3):455-64. PMID: 11858629.
Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. PMID: 9293187.
Aldred KJ, McPherson SA, Wang P, et al. Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance. Biochemistry. 2012 Jan 10;51(1):370-381. PMID: 22126453.
